Sampre Nutritions Complete Financial Statements
In FY2025, Sampre Nutritions (SAMPRE) reported revenue ₹10 Cr, net profit ₹1 Cr and EPS ₹0.41, with a net profit margin of 10.0% and ROE of 1.1%. Full financial statements from FY2023 to FY2025 (3 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see SAMPRE company profile.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
SAMPRE Revenue, Net Profit & EBITDA — Year-on-Year Growth
SAMPRE YoY (Sept 2024 vs Sept 2025) — revenue +42.9%, EBITDA +100.0%, expenses +33.3%.
SAMPRE Income Statement — Revenue, EBITDA & Net Profit
Sampre Nutritions revenue ₹10 Cr, EBITDA ₹2 Cr, net profit ₹1 Cr, EPS ₹0.41 (2025) — net profit margin 10.0%. Explore Sampre Nutritions intrinsic price to estimate fundamental worth using multiple valuation models.
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 10 | 8 | 11 | 7 | 7 | 5 | 5 | 6 |
| Expenses | 8 | 14 | 10 | 6 | 6 | 3 | 4 | 5 |
| EBITDA | 2 | -6 | 1 | 2 | 1 | 2 | 1 | 1 |
| Operating Profit Margin % | 20.00% | -81.00% | 13.00% | 20.00% | 14.00% | 43.00% | 21.00% | 8.00% |
| Depreciation | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 0 |
| Interest | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 |
| Profit Before Tax | 1 | -7 | 1 | 1 | 0 | 1 | 0 | -1 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 1 | -7 | 1 | 1 | 0 | 1 | 0 | -1 |
| Earnings Per Share (₹) | 0.41 | -3.50 | 0.34 | 0.06 | 0.18 | 0.65 | 0.11 | -0.30 |
SAMPRE Balance Sheet — Assets, Liabilities & Shareholders' Equity
SAMPRE total assets ₹115 Cr, total equity ₹91 Cr, total liabilities ₹ Cr (2025) — ROE 1.1%.
| Particulars | 2025 | 2024 | 2023 |
|---|---|---|---|
| ASSETS | |||
| Total Assets | 115 | 45 | 44 |
| Current Assets | 16 | 16 | 16 |
| Fixed Assets | 20 | 21 | 21 |
| Capital Work in Progress | 5 | 6 | 4 |
| Investments | 74 | 0 | 0 |
| Other Assets | 17 | 18 | 19 |
| LIABILITIES | |||
| Total Liabilities | |||
| Current Liabilities | 11 | 10 | 11 |
| Non-Current Liabilities | |||
| SHAREHOLDERS' EQUITY | |||
| Total Equity | 91 | 23 | 21 |
| Share Capital | 21 | 7 | 7 |
| Reserves & Surplus | 68 | 12 | 12 |
SAMPRE Cash Flow Statement — Operating, Investing & Financing
Sampre Nutritions operating cash flow ₹0 Cr, investing ₹-75 Cr, financing ₹75 Cr, net cash flow ₹0 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 |
|---|---|---|---|
| Operating Activities | 0 | 4 | 1 |
| Investing Activities | -75 | -4 | -4 |
| Financing Activities | 75 | 0 | 4 |
| Net Cash Flow | 0 | 0 | 0 |